Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis

Abstract

In a large retrospective cohort of patients with UC who were new users of anti-TNF agents, IFX-treated patients may have lower corticosteroid use than ADA-treated patients, but risk of hospitalisation and serious infections were comparable.